- Home
- ZGN vs MANE Comparison
ZGN vs MANE Comparison
Compare ZGN & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZGN | MANE |
|---|---|---|
| Founded | 1910 | 2019 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.3B |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ZGN | MANE |
|---|---|---|
| Price | $11.60 | $103.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $11.28 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 1.1M | 520.8K |
| Earning Date | 03-20-2026 | 03-30-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $7.89 | N/A |
| P/E Ratio | $25.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.64 | $36.26 |
| 52 Week High | $15.95 | $131.24 |
Technical Indicators
Market Signals| Indicator | ZGN | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 23.10 | 48.15 |
| Support Level | $11.41 | $94.68 |
| Resistance Level | $11.86 | $116.86 |
| Average True Range (ATR) | 0.42 | 4.66 |
| MACD | -0.18 | 0.26 |
| Stochastic Oscillator | 9.13 | 66.45 |
Price Performance
Historical ComparisonAbout ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of revenue from the Zegna segment.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.